ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,933Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 307

$655K Total Retail Price of All Prescriptions

Rank: 10 out of 307

510 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,443 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 680 493 1 1
SIMVASTATIN 510 374 2 2
HYDROCODONE-ACETAMINOPHEN 409 234 S3 3 4
OMEPRAZOLE 338 194 4 5
LISINOPRIL 309 202 5 3
ZOLPIDEM TARTRATE 283 207 6 19
METFORMIN HCL 261 167 7 8
AMLODIPINE BESYLATE 254 187 8 7
TRAMADOL HCL 246 133 9 25
FUROSEMIDE 239 182 10 6
POTASSIUM CHLORIDE 190 150 11 10
HYDROCHLOROTHIAZIDE 187 145 12 9
METOPROLOL TARTRATE 170 132 13 12
METOPROLOL SUCCINATE 165 126 14 13
LOSARTAN POTASSIUM 163 141 15 16
MORPHINE SULFATE ER 142 30 S2 16 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 133 17 23
CITALOPRAM HBR 133 99 18 14
PRAVASTATIN SODIUM 127 99 19 26
ALENDRONATE SODIUM 119 81 20 20
ATORVASTATIN CALCIUM 116 101 21 18
PAROXETINE HCL 115 44 22 43
CYCLOBENZAPRINE HCL 112 40 R 23 75
ADVAIR DISKUS 110 78 24 28
CYMBALTA 107 67 25 30
HYDROMORPHONE HCL 107 0 S2 25 119
COMBIVENT 106 45 27 90
NEXIUM 102 49 28 38
FLUOXETINE HCL 98 58 29 32
SERTRALINE HCL 98 69 29 22
TRIAMTERENE-HCTZ 92 88 31 42
RANITIDINE HCL 89 40 32 57
MIRTAZAPINE 88 42 33 51
SINGULAIR 87 42 34 100
ATENOLOL 87 85 34 17
FLUTICASONE PROPIONATE 86 48 36 44
GABAPENTIN 84 26 37 15
PREDNISONE 80 57 38 37
MELOXICAM 77 42 39 29
JANUVIA 77 59 39 97
EVISTA 75 75 41 107
ACETAMINOPHEN-CODEINE 71 68 S3 42 86
TRAZODONE HCL 71 43 42 33
LOSARTAN-HYDROCHLOROTHIAZIDE 69 63 44 46
SPIRONOLACTONE 66 60 45 40
ROPINIROLE HCL 65 43 46 74
MONTELUKAST SODIUM 62 26 47 202
NORTRIPTYLINE HCL 62 46 47 142
CARVEDILOL 60 52 49 24
ENALAPRIL MALEATE 59 42 50 54
LANTUS 59 33 50 47
DIOVAN 59 58 50 58
WARFARIN SODIUM 58 47 53 11
FENTANYL 58 25 S2 53 35
LOVASTATIN 55 52 55 45
ESTRADIOL 54 43 R 56 151
AMITRIPTYLINE HCL 51 0 R 57 65
VENTOLIN HFA 50 16 58 98
VENLAFAXINE HCL ER 50 32 58 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.